Market Place
Sourcing Support
Intravacc and Primrose Announce Partnership to Enhance Conj Vaccine Development
28 Mar 2024 //
GLOBENEWSWIRE
Intravacc and Primrose Bio Partner to Enhance Conjugate Vaccine Development
28 Mar 2024 //
BIOSPACE
Intravacc Reports Positive Data For Intranasal OMV SARS-CoV-2 Vaccine
26 Mar 2024 //
PRESS RELEASE
Intravacc announces positive data of intranasal OMV based vaccine for SARS-CoV-2
26 Mar 2024 //
GLOBENEWSWIRE
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine
16 Jan 2024 //
GLOBENEWSWIRE
Intravacc Gets $633K CARB-X Funding For Gonorrhea Vaccine Development
11 Jan 2024 //
PRESS RELEASE
Intravacc launches new website with a wealth of scientific knowledge
20 Dec 2023 //
GLOBENEWSWIRE
Intravacc announces publication of In Vitro alternative to replace pyrogen test
19 Sep 2023 //
GLOBENEWSWIRE
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines
14 Sep 2023 //
GLOBENEWSWIRE
Intravacc`s CSO Virgil Schijns appointed as Professor at Scottish University
23 Feb 2023 //
PR NEWSWIRE
Intravacc Announces Data for its Candidate Intranasal Gonorrhea Vaccine Avacc 11
16 Jan 2023 //
PR NEWSWIRE
Intravacc launches phase I clinical trial of Avacc 10®, an intranasal subunit
30 Nov 2022 //
PRNEWSWIRE
Intravacc enrols first subject in intranasal Covid-19 booster trial
30 Nov 2022 //
CLINICALTRIALSARENA
EpiVax joins Intravacc, CEPI on project to develop betacoronavirus vaccine
31 Oct 2022 //
PHARMABIZ
NIH awards $15M contract to Intravacc`s nasal gonorrhea vaccine
11 Oct 2022 //
FIERCEPHARMA
CEPI partners with Intravacc to develop an intranasal vaccine
06 Oct 2022 //
PRNEWSWIRE
Dutch CDMO Intravacc gets NIH grant of up to $14.6M to make gonorrhea vaccine
06 Oct 2022 //
ENPTS
Intravacc announces preclinical and toxicology data for Avacc 10
12 Sep 2022 //
PRNEWSWIRE
Intravacc and DZNE awarded EU funding to develop vaccine against genetic ALS
06 Jul 2022 //
PRNEWSWIRE
Intravacc publishes 2021 annual report and announces expansion of board
05 Jul 2022 //
PRNEWSWIRE
Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharma
02 May 2022 //
PRNEWSWIRE
Intravacc publishes GMP process for Shigella glycoconjugate vaccine candidate
22 Mar 2022 //
PRNEWSWIRE
Intravacc, LUMC partner for phase I/II study of new intranasal corona vaccine
06 Jan 2022 //
PHARMABIZ
Vaccine Developer Intravacc Adopts Hybrid Business Model
16 Sep 2021 //
CONTRACTPHARMA
Intravacc`s Inactivated Polio Vaccine Out-licensed to Sinovac
21 Jul 2021 //
CONTRACT PHARMA
Intravacc announces positive preclinical data for its OMV-based Lyme vaccine
13 Apr 2021 //
PRNESWIRE
Intravacc announces positive preclinical data for its SARS-CoV-2
07 Apr 2021 //
PRNEWSWIRE
Intravacc announces positive preclinical data for its SARS-CoV-2 nose
06 Apr 2021 //
PRNEWSWIRE
Intravacc Unveils New Pilot Vaccine Production Facility
19 Feb 2021 //
CONTRACTPHARMA
Intravacc Unveils New Pilot Vaccine Production Facility
19 Feb 2021 //
CONTRACTPHARMA
Intravacc`s Sabin Inactivated Polio vaccine (sIPV), out-licensed to LG Chem
21 Jan 2021 //
PRNEWSWIRE
Intravacc`s Sabin Inactivated Polio vaccine , out-licensed to LG Chem, WHO
21 Jan 2021 //
PRNEWSWIRE
CDSCO issues guidance document on license for import or manufacture
21 Jan 2021 //
PHARMABIZ
Intravacc announces completion of formulation and MFG process devP of PRV-101
20 Jan 2021 //
PRNEWSWIRE
Intravacc Completes Project for Provention Bio’s Vax Candidate
19 Jan 2021 //
CONTRACTPHARMA
Intravacc announces completion of formulation and manufacturing of PRV-101
19 Jan 2021 //
PRNEWSWIRE
Intravacc announces completion of formulation and MFG process devPof PRV-101
18 Jan 2021 //
PRNEWSWIRE
Intravacc, Cristal Therapeutics Collaborate on Novel Vaccine Platforms
07 Jan 2021 //
PHARMTECH
Cristal Therapeutics and Intravacc Announce Strategic Collaboration
06 Jan 2021 //
PRNEWSWIRE
Intravacc publishes positive phase I Shigella conjugate vaccine data
16 Nov 2020 //
PHARMABIZ
Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine
07 Sep 2020 //
PRESS RELEASE
Intravacc, Therapyx develop world`s first prophylactic gonorrhea vaccine
25 Aug 2020 //
BIOSPECTRUM
Intravacc and Therapyx jointly develop the world`s first prophylactic gonorrhea
24 Aug 2020 //
PRESS RELEASE
Intravacc reports positive data from Phase I trial of RSV vaccine
18 Aug 2020 //
PRESS RELEASE
Intravacc and Celonic team up to develop Covid-19 vaccine
30 Jul 2020 //
PHARMACEUTICAAL-TECHNOLOGY
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine
29 Jul 2020 //
PRNEWSWIRE
Intravacc, CimCure partner on cancer, COVID-19 vaccines
02 Jul 2020 //
WWW.SCIENCEBOARD.NET/INDEX
Intranasal immunization With Intravacc`s Experimental Whooping Cough Vaccine
21 Jun 2020 //
PRNEWSWIRE
Intravacc and EpiVax to develop Covid-19 vaccine candidate
02 Jun 2020 //
PHARMACEUTICAL-TECHNOLOGY
Intravacc and EpiVax Team up in Development of COVID-19 Emerging Vaccine
02 Jun 2020 //
PRNEWSWIRE
